DECIPHERA PHARMACEUTICALS IN's ticker is and the CUSIP is 24344T901. A total of 3 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,544 | -69.9% | 200 | -66.7% | 0.00% | – |
| Q2 2023 | $8,448 | +82.3% | 600 | +100.0% | 0.00% | – |
| Q1 2023 | $4,635 | -91.2% | 300 | -90.6% | 0.00% | – |
| Q4 2022 | $52,448 | -11.1% | 3,200 | 0.0% | 0.00% | – |
| Q3 2022 | $59,000 | -41.6% | 3,200 | -58.4% | 0.00% | – |
| Q2 2022 | $101,000 | -20.5% | 7,700 | -43.8% | 0.00% | – |
| Q1 2022 | $127,000 | -78.8% | 13,700 | -77.6% | 0.00% | – |
| Q4 2021 | $598,000 | +1358.5% | 61,200 | +5000.0% | 0.00% | – |
| Q3 2021 | $41,000 | -41.4% | 1,200 | -36.8% | 0.00% | – |
| Q2 2021 | $70,000 | -85.8% | 1,900 | -82.7% | 0.00% | -100.0% |
| Q1 2021 | $493,000 | -72.6% | 11,000 | -65.1% | 0.00% | -66.7% |
| Q4 2020 | $1,798,000 | +93.5% | 31,500 | +74.0% | 0.00% | 0.0% |
| Q3 2020 | $929,000 | +1.6% | 18,100 | +18.3% | 0.00% | -25.0% |
| Q2 2020 | $914,000 | +50.1% | 15,300 | +3.4% | 0.00% | -20.0% |
| Q1 2020 | $609,000 | -52.5% | 14,800 | -28.2% | 0.01% | -44.4% |
| Q4 2019 | $1,282,000 | +1014.8% | 20,600 | +505.9% | 0.01% | +800.0% |
| Q3 2019 | $115,000 | +2775.0% | 3,400 | +3300.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 200 | $2 | 0.00% |
| GROUP ONE TRADING, L.P. | 200 | $2,544 | 0.00% |